Page 2070 - Week 05 - Thursday, 6 May 2010

Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video

---

(c) To respect the privacy and confidentiality of individuals concerned, ACT Health will not release the details of damages which may identify them.

(d)

The amounts above reflect payments made by ACT Health, and on behalf of ACT Health, by the ACTIA. They are shown gross of reinsurance recoveries and agency insurance excess payments.

(5)

The figures above represent costs incurred in investigating matters that do not eventuate into a claim. Costs incurred in investigating matters that eventuate into a claim are included at (1).

(6) The matters investigated above include alleged medical negligence, public liability, professional indemnity, directors and officers incidents.

Alexander Maconochie Centre—needle and syringe program
(Question No 906)

Mr Hanson asked the Attorney-General, upon notice, on 25 March 2010:

(1) What work has been conducted by ACT Corrective Services (ACTCS) to date in relation to the need for a Needle Syringe Program (NSP) at the Alexander Maconochie Centre (AMC).

(2) What is the progress or status of any such reviews into the need for such a program and are any preliminary findings of the review supportive of the introduction of an NSP at the AMC.

(3) Since the commencement of operations at the AMC, has bleach, or another cleaning agent, been provided to prisoners; if so, how many litres of bleach have been provided since the commencement of operations.

(4) What opportunity will ACTCS staff, particularly correctional officers, have to share their views about the need to introduce an NSP at the AMC.

Mr Corbell: The answer to the member’s question is as follows:

---

Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video